HealthTree

Your Feed

Filter by

See content from

Back to the latest

First-Ever FDA Approved CAR T-Cell Therapy for R/R CLL: Liso-cel (Breyanzi)

First-Ever FDA Approved CAR T-Cell Therapy for R/R CLL: Liso-cel (Breyanzi) image

How Can Real World Data Accelerate CLL Research?

How Can Real World Data Accelerate CLL Research? image

Treating Pediatric AML

Treating Pediatric AML image

Mindfulness for AML Patients: Thought Defusion

Mindfulness for AML Patients: Thought Defusion image

Mindfulness for CLL Patients: Thought Defusion

Mindfulness for CLL Patients: Thought Defusion image

The Importance Of Glucose Levels And Cancer Cells

The Importance Of Glucose Levels And Cancer Cells image

Revolutionizing CAR T-Cell Therapy: A Breakthrough in Patient Care

Revolutionizing CAR T-Cell Therapy: A Breakthrough in Patient Care image

Bisantrene Combination Therapy A Promising Treatment For R/R AML

Bisantrene Combination Therapy A Promising Treatment For R/R AML image

Vitamins C And D Benefit Patients During Intensive Chemotherapy

Vitamins C And D Benefit Patients During Intensive Chemotherapy image

Recipes for CLL Patients: Wild Blueberry Oat Bars

Recipes for CLL Patients: Wild Blueberry Oat Bars image

A New Study: Danvatirsen For AML

A New Study: Danvatirsen For AML image

HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma

HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma image

Pediatric AML: What Does It Look Like?

Pediatric AML: What Does It Look Like? image

Diane’s CLL Story - Empowered Through Education and Wellness Methods

Diane’s CLL Story - Empowered Through Education and Wellness Methods image

Familial AML With The CEBPA Mutation

Familial AML With The CEBPA Mutation image

ASH 2023: FLT3 Inhibitors Gilteritinib and Quizartinib as AML Maintenance Therapies

ASH 2023: FLT3 Inhibitors Gilteritinib and Quizartinib as AML Maintenance Therapies image

ASH 2023: Prognostic significance of Malnutrition and sarcopenia in older adults with AML.

ASH 2023: Prognostic significance of Malnutrition and sarcopenia in older adults with AML. image

ASH 2023: A Fully Oral Medicine Combination for Frail AML Patients

ASH 2023: A Fully Oral Medicine Combination for Frail AML Patients image

ASH 2023: A Multi-center, Retrospective Analysis of AML Patients

ASH 2023: A Multi-center, Retrospective Analysis of AML Patients image

ASH 2023: Do CLL Patients Prefer Fixed-Duration or Continuous-Duration Therapy?

ASH 2023: Do CLL Patients Prefer Fixed-Duration or Continuous-Duration Therapy? image

Finding Financial Support and Resources for Your CLL Treatment image

Finding Financial Support and Resources for Your CLL Treatment

01:00PM - 02:00PM EST

Watch Recording

Glowther

Chronic Lymphocytic Leukemia Discussion • February 12, 2024

Not Seeing Any Posts in the Feed?

AI-generated title

Where are all the other posts?

ASH 2023: How Effective is Venetoclax After a BTK Inhibitor for CLL?

ASH 2023: How Effective is Venetoclax After a BTK Inhibitor for CLL? image

Negotiating Medical and Other Debt

Negotiating Medical and Other Debt image

More from HealthTree